These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 37665256)
1. [Several heart conditions are related to increased risk of ischemic stroke and TIA]. G Lindgren A; Wester P Lakartidningen; 2023 Sep; 120():. PubMed ID: 37665256 [TBL] [Abstract][Full Text] [Related]
2. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack. Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232 [TBL] [Abstract][Full Text] [Related]
3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L; JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and Management of Cardioembolic Stroke. Yaghi S Continuum (Minneap Minn); 2023 Apr; 29(2):462-485. PubMed ID: 37039405 [TBL] [Abstract][Full Text] [Related]
5. Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis. Ntaios G; Papavasileiou V; Sagris D; Makaritsis K; Vemmos K; Steiner T; Michel P Stroke; 2018 Feb; 49(2):412-418. PubMed ID: 29335335 [TBL] [Abstract][Full Text] [Related]
6. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Aguilar MI; Hart R; Pearce LA Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831 [TBL] [Abstract][Full Text] [Related]
7. Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale. Casaubon L; McLaughlin P; Webb G; Yeo E; Merker D; Jaigobin C Can J Neurol Sci; 2007 Feb; 34(1):74-80. PubMed ID: 17352351 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of patent foramen ovale closure versus medical therapy for prevention of recurrent ischemic neurological events: Impact of medication type. Pan X; Xu L; Zhou C; Zhang Z; Sun H Medicine (Baltimore); 2021 Jun; 100(25):e26473. PubMed ID: 34160457 [TBL] [Abstract][Full Text] [Related]
9. Stroke subtypes and interventional studies for transient ischemic attack. Lavallée P; Amarenco P Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562 [TBL] [Abstract][Full Text] [Related]
10. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience. Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514 [TBL] [Abstract][Full Text] [Related]
11. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials. Vaduganathan M; Qamar A; Gupta A; Bajaj N; Golwala HB; Pandey A; Bhatt DL Am J Med; 2018 May; 131(5):575-577. PubMed ID: 29229471 [TBL] [Abstract][Full Text] [Related]